| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Assessment of microRNA and gene dysregulation in pulmonary hypertension by endoarterial biopsy
|
Rothman, Abraham
|
|
2017
|
7 |
2 |
p. 455-464
|
artikel
|
| 2 |
A systematic review of transition studies of pulmonary arterial hypertension specific medications
|
Sofer, Avraham
|
|
2017
|
7 |
2 |
p. 326-338
|
artikel
|
| 3 |
Characteristics of pediatric pulmonary hypertension trials registered on ClinicalTrials.gov
|
Awerbach, Jordan D.
|
|
2017
|
7 |
2 |
p. 348-360
|
artikel
|
| 4 |
Circulatory power and ventilatory power over time under goal-oriented sequential combination therapy for pulmonary arterial hypertension
|
Hirashiki, Akihiro
|
|
2017
|
7 |
2 |
p. 448-454
|
artikel
|
| 5 |
Combination therapy in pulmonary arterial hypertension: recent accomplishments and future challenges
|
Lajoie, Annie-Christine
|
|
2017
|
7 |
2 |
p. 312-325
|
artikel
|
| 6 |
Corrigendum
|
|
|
2017
|
7 |
2 |
p. 559
|
artikel
|
| 7 |
Dobutamine stress MRI in pulmonary hypertension: relationships between stress pulmonary artery relative area change, RV performance, and 10-year survival
|
Blyth, Kevin G.
|
|
2017
|
7 |
2 |
p. 465-475
|
artikel
|
| 8 |
First-in-child use of the oral selective prostacyclin IP receptor agonist selexipag in pulmonary arterial hypertension
|
Geerdink, Lianne M.
|
|
2017
|
7 |
2 |
p. 551-554
|
artikel
|
| 9 |
Follow-up tricuspid annular plane systolic excursion predicts survival in pulmonary arterial hypertension
|
Mazurek, Jeremy A.
|
|
2017
|
7 |
2 |
p. 361-371
|
artikel
|
| 10 |
Genomic stability of pulmonary artery endothelial colony-forming cells in culture
|
Drake, Kylie M.
|
|
2017
|
7 |
2 |
p. 421-427
|
artikel
|
| 11 |
Identifying “super responders” in pulmonary arterial hypertension
|
Halliday, Stephen J.
|
|
2017
|
7 |
2 |
p. 300-311
|
artikel
|
| 12 |
Improved metabolism and redox state with a novel preservation solution: implications for donor lungs after cardiac death (DCD)
|
Schipper, David A.
|
|
2017
|
7 |
2 |
p. 494-504
|
artikel
|
| 13 |
Increased mortality from complications of pulmonary hypertension in patients undergoing transcatheter aortic valve replacement
|
Parikh, Raj
|
|
2017
|
7 |
2 |
p. 391-398
|
artikel
|
| 14 |
Inspiratory capacity is not altered in operable chronic thromboembolic pulmonary hypertension
|
Richter, Manuel J.
|
|
2017
|
7 |
2 |
p. 543-546
|
artikel
|
| 15 |
Lack of elevation in plasma levels of pro-inflammatory cytokines in common rodent models of pulmonary arterial hypertension: questions of construct validity for human patients
|
Schlosser, Kenny
|
|
2017
|
7 |
2 |
p. 476-485
|
artikel
|
| 16 |
Late-onset pulmonary arterial hypertension in repaired D-transposition of great arteries: an uncommon complication
|
Baskaran, Janani
|
|
2017
|
7 |
2 |
p. 547-550
|
artikel
|
| 17 |
Longitudinal change in pulmonary arterial capacitance as an indicator of prognosis and response to therapy and in pulmonary arterial hypertension
|
Medrek, Sarah K.
|
|
2017
|
7 |
2 |
p. 399-408
|
artikel
|
| 18 |
Metabolic and Functional Evaluation of the Heart and Lungs in Pulmonary Hypertension by Gated 2-[18F]-Fluoro-2-deoxy-D-glucose Positron Emission Tomography
|
Saygin, Didem
|
|
2017
|
7 |
2 |
p. 428-438
|
artikel
|
| 19 |
MicroCT analysis of vascular morphometry: a comparison of right lung lobes in the SUGEN/hypoxic rat model of pulmonary arterial hypertension
|
Faight, Erin M.
|
|
2017
|
7 |
2 |
p. 522-530
|
artikel
|
| 20 |
Novel approach to classifying patients with pulmonary arterial hypertension using cluster analysis
|
Parikh, Kishan S.
|
|
2017
|
7 |
2 |
p. 486-493
|
artikel
|
| 21 |
Open label study of ambrisentan in patients with exercise pulmonary hypertension
|
Segrera, Sergio A.
|
|
2017
|
7 |
2 |
p. 531-538
|
artikel
|
| 22 |
Phosphodiesterase type 5 inhibitor to riociguat transition is associated with hemodynamic and symptomatic improvement in pulmonary hypertension
|
Davey, Ryan
|
|
2017
|
7 |
2 |
p. 539-542
|
artikel
|
| 23 |
Poor survival in patients with scleroderma and pulmonary hypertension due to heart failure with preserved ejection fraction
|
Bourji, Khalil I.
|
|
2017
|
7 |
2 |
p. 409-420
|
artikel
|
| 24 |
Prostacyclins have no direct inotropic effect on isolated atrial strips from the normal and pressure-overloaded human right heart
|
Holmboe, Sarah
|
|
2017
|
7 |
2 |
p. 339-347
|
artikel
|
| 25 |
Pulmonary arterial hypertension: Specialists’ knowledge, practices, and attitudes of genetic counseling and genetic testing in the USA
|
Jacher, Joseph E.
|
|
2017
|
7 |
2 |
p. 372-383
|
artikel
|
| 26 |
Pulmonary venous remodeling in COPD-pulmonary hypertension and idiopathic pulmonary arterial hypertension
|
Andersen, Kasper Hasseriis
|
|
2017
|
7 |
2 |
p. 514-521
|
artikel
|
| 27 |
Right ventricular ST-elevation myocardial infarction as a cause of death in idiopathic pulmonary arterial hypertension
|
Zhan, Yang
|
|
2017
|
7 |
2 |
p. 555-558
|
artikel
|
| 28 |
The cancer theory of pulmonary arterial hypertension
|
Boucherat, Olivier
|
|
2017
|
7 |
2 |
p. 285-299
|
artikel
|
| 29 |
The Modified Borg Dyspnea Scale does not predict hospitalization in pulmonary arterial hypertension
|
Banerjee, Debasree
|
|
2017
|
7 |
2 |
p. 384-390
|
artikel
|
| 30 |
The Pulmonary Vascular Research Institute celebrates its first decade
|
Yuan, Jason X.-J.
|
|
2017
|
7 |
2 |
p. 283-284
|
artikel
|
| 31 |
The safety and pharmacokinetics of rapid iloprost aerosol delivery via the BREELIB nebulizer in pulmonary arterial hypertension
|
Gessler, Tobias
|
|
2017
|
7 |
2 |
p. 505-513
|
artikel
|
| 32 |
Withdrawal of long-term epoprostenol therapy in pulmonary arterial hypertension (PAH)
|
Calcaianu, George
|
|
2017
|
7 |
2 |
p. 439-447
|
artikel
|
Tijdschrift beschrijving